Vaccination campaign picks up speed around the world - News 1130 | Canada News Media
Connect with us

Health

Vaccination campaign picks up speed around the world – News 1130

Published

 on


The campaign to vanquish the coronavirus is picking up speed, with Britain beginning to dispense the second vaccine in its arsenal Monday, and India, the world’s second-most populous country, authorizing its first shots.

In the U.S., meanwhile, government officials reported that vaccinations have accelerated markedly after a disappointingly slow start. Dr. Anthony Fauci, the nation’s top infectious-disease expert, said over the weekend that 1.5 million shots were administered in 72 hours, bringing the total to about 4 million.

Britain on Monday became the first nation to start using the COVID-19 vaccine developed by AstraZeneca and Oxford University, ramping up its nationwide inoculation campaign amid soaring infection rates blamed on a new and seemingly more contagious variant of the virus.

Brian Pinker, an 82-year-old dialysis patient, received the first shot at Oxford University Hospital, saying in statement: “I can now really look forward to celebrating my 48th wedding anniversary.”

Britain’s mass vaccination program began Dec. 8 with the shot developed by Pfizer and its German partner BioNTech.

The country has recorded more than 50,000 new coronavirus infections a day over the past six days, and deaths have climbed past 75,000, one of the worst tolls in Europe.

Prime Minister Boris Johnson announced a wave of near-lockdowns the weekend before Christmas and warned on Monday that “tough, tough” weeks lie ahead and that more restrictions are coming soon: “If you look at the numbers, there’s no question we will have to take tougher measures and we will be announcing those in due course.”

Those measures could include more schools closings, curfews and a total ban on the mixing of people from different households.

On Sunday, India authorized two COVID-19 vaccines — the Oxford-AstraZeneca one and another developed by an Indian company — paving the way for a huge inoculation program to stem the outbreak in the desperately poor country of about 1.4 billion people.

Prime Minister Narendra Modi called it a “decisive turning point to strengthen a spirited fight.”

But questions have been raised by health experts over the vaccine developed by India’s Bharat Biotech. They point out that clinical trials did not begin until mid-November, making it almost impossible for the company to have analyzed and submitted data showing its shots are effective.

India has confirmed more than 10.3 million cases of the virus, second in the world behind the U.S. It also has reported about 150,000 deaths.

The country’s initial immunization plan aims to vaccinate 300 million people — health care workers, front-line staff including police, and those considered vulnerable because of their age or other diseases — by August.

Neither of the approved vaccines requires the ultra-cold storage facilities that some others do. Instead, they can kept in refrigerators, making them more feasible for the country.

In the U.S., the rollout has been marked by a multitude of logistical hurdles, a patchwork of approaches by state and local governments, and confusion. Some people are uncertain where or when to get a shot.

Fauci said over the weekend that he saw “some little glimmer of hope” in the stepped-up rate of vaccinations. He acknowledged the U.S. fell short of its goal of having 20 million doses shipped and distributed by the end of December, saying, “We are not where we want to be.”

But he expressed optimism that the momentum will pick up by mid-January and that ultimately the U.S. will be vaccinating 1 million people a day. He said President-elect Joe Biden’s goal of vaccinating 100 million people in his first 100 days in office is “realistic.”

The European Union, meanwhile, defended its vaccination strategy Monday amid growing criticism about the slow rollout of COVID-19 shots across the 27-nation bloc of 450 million inhabitants.

EU Commission spokesman Eric Mamer said the main problem “is an issue of production capacity, an issue that everybody is facing.”

The EU has sealed six vaccines contracts with a variety of manufacturers. But only the Pfizer-BioNTech vaccine has been approved for use so far across the EU. The EU’s drug regulators are expected to decide on Wednesday whether to recommend authorizing the Moderna vaccine.

Aspects of Britain’s vaccination plans have also spurred controversy.

Both of the vaccines it is using require two shots, and Pfizer has recommended that the second dose be given within 21 days. But British health authorities want to give the first dose to as many people as possible right away, rather than setting aside vaccine to ensure people get their second shot on time. The plan requires stretching out the time between the doses from 21 days to within 12 weeks.

While two doses are required to fully protect against COVID-19, one dose offers a high level of protection.

Stephen Evans, a professor of pharmacoepidemiology at the London School of Hygiene & Tropical Medicine, said policymakers are being forced to balance the potential risks and benefits in the middle of the disaster.

“We have a crisis situation in the UK with a new variant spreading rapidly, and as has become clear to everyone during 2020, delays cost lives,” Evans said. “When resources of doses and people to vaccinate are limited, then vaccinating more people with potentially less efficacy is demonstrably better than a fuller efficacy in only half.”

Danica Kirka And Aniruddha Ghosal, The Associated Press

Let’s block ads! (Why?)



Source link

Continue Reading

Health

Canada to donate up to 200,000 vaccine doses to combat mpox outbreaks in Africa

Published

 on

 

The Canadian government says it will donate up to 200,000 vaccine doses to fight the mpox outbreak in Congo and other African countries.

It says the donated doses of Imvamune will come from Canada’s existing supply and will not affect the country’s preparedness for mpox cases in this country.

Minister of Health Mark Holland says the donation “will help to protect those in the most affected regions of Africa and will help prevent further spread of the virus.”

Dr. Madhukar Pai, Canada research chair in epidemiology and global health, says although the donation is welcome, it is a very small portion of the estimated 10 million vaccine doses needed to control the outbreak.

Vaccine donations from wealthier countries have only recently started arriving in Africa, almost a month after the World Health Organization declared the mpox outbreak a public health emergency of international concern.

A few days after the declaration in August, Global Affairs Canada announced a contribution of $1 million for mpox surveillance, diagnostic tools, research and community awareness in Africa.

On Thursday, the Africa Centres for Disease Control and Prevention said mpox is still on the rise and that testing rates are “insufficient” across the continent.

Jason Kindrachuk, Canada research chair in emerging viruses at the University of Manitoba, said donating vaccines, in addition to supporting surveillance and diagnostic tests, is “massively important.”

But Kindrachuk, who has worked on the ground in Congo during the epidemic, also said that the international response to the mpox outbreak is “better late than never (but) better never late.”

“It would have been fantastic for us globally to not be in this position by having provided doses a much, much longer time prior than when we are,” he said, noting that the outbreak of clade I mpox in Congo started in early 2023.

Clade II mpox, endemic in regions of West Africa, came to the world’s attention even earlier — in 2022 — as that strain of virus spread to other countries, including Canada.

Two doses are recommended for mpox vaccination, so the donation may only benefit 100,000 people, Pai said.

Pai questioned whether Canada is contributing enough, as the federal government hasn’t said what percentage of its mpox vaccine stockpile it is donating.

“Small donations are simply not going to help end this crisis. We need to show greater solidarity and support,” he said in an email.

“That is the biggest lesson from the COVID-19 pandemic — our collective safety is tied with that of other nations.”

This report by The Canadian Press was first published Sept. 13, 2024.

Canadian Press health coverage receives support through a partnership with the Canadian Medical Association. CP is solely responsible for this content.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Health

How many Nova Scotians are on the doctor wait-list? Number hit 160,000 in June

Published

 on

 

HALIFAX – The Nova Scotia government says it could be months before it reveals how many people are on the wait-list for a family doctor.

The head of the province’s health authority told reporters Wednesday that the government won’t release updated data until the 160,000 people who were on the wait-list in June are contacted to verify whether they still need primary care.

Karen Oldfield said Nova Scotia Health is working on validating the primary care wait-list data before posting new numbers, and that work may take a matter of months. The most recent public wait-list figures are from June 1, when 160,234 people, or about 16 per cent of the population, were on it.

“It’s going to take time to make 160,000 calls,” Oldfield said. “We are not talking weeks, we are talking months.”

The interim CEO and president of Nova Scotia Health said people on the list are being asked where they live, whether they still need a family doctor, and to give an update on their health.

A spokesperson with the province’s Health Department says the government and its health authority are “working hard” to turn the wait-list registry into a useful tool, adding that the data will be shared once it is validated.

Nova Scotia’s NDP are calling on Premier Tim Houston to immediately release statistics on how many people are looking for a family doctor. On Tuesday, the NDP introduced a bill that would require the health minister to make the number public every month.

“It is unacceptable for the list to be more than three months out of date,” NDP Leader Claudia Chender said Tuesday.

Chender said releasing this data regularly is vital so Nova Scotians can track the government’s progress on its main 2021 campaign promise: fixing health care.

The number of people in need of a family doctor has more than doubled between the 2021 summer election campaign and June 2024. Since September 2021 about 300 doctors have been added to the provincial health system, the Health Department said.

“We’ll know if Tim Houston is keeping his 2021 election promise to fix health care when Nova Scotians are attached to primary care,” Chender said.

This report by The Canadian Press was first published Sept. 11, 2024.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Health

Newfoundland and Labrador monitoring rise in whooping cough cases: medical officer

Published

 on

 

ST. JOHN’S, N.L. – Newfoundland and Labrador‘s chief medical officer is monitoring the rise of whooping cough infections across the province as cases of the highly contagious disease continue to grow across Canada.

Dr. Janice Fitzgerald says that so far this year, the province has recorded 230 confirmed cases of the vaccine-preventable respiratory tract infection, also known as pertussis.

Late last month, Quebec reported more than 11,000 cases during the same time period, while Ontario counted 470 cases, well above the five-year average of 98. In Quebec, the majority of patients are between the ages of 10 and 14.

Meanwhile, New Brunswick has declared a whooping cough outbreak across the province. A total of 141 cases were reported by last month, exceeding the five-year average of 34.

The disease can lead to severe complications among vulnerable populations including infants, who are at the highest risk of suffering from complications like pneumonia and seizures. Symptoms may start with a runny nose, mild fever and cough, then progress to severe coughing accompanied by a distinctive “whooping” sound during inhalation.

“The public, especially pregnant people and those in close contact with infants, are encouraged to be aware of symptoms related to pertussis and to ensure vaccinations are up to date,” Newfoundland and Labrador’s Health Department said in a statement.

Whooping cough can be treated with antibiotics, but vaccination is the most effective way to control the spread of the disease. As a result, the province has expanded immunization efforts this school year. While booster doses are already offered in Grade 9, the vaccine is now being offered to Grade 8 students as well.

Public health officials say whooping cough is a cyclical disease that increases every two to five or six years.

Meanwhile, New Brunswick’s acting chief medical officer of health expects the current case count to get worse before tapering off.

A rise in whooping cough cases has also been reported in the United States and elsewhere. The Pan American Health Organization issued an alert in July encouraging countries to ramp up their surveillance and vaccination coverage.

This report by The Canadian Press was first published Sept. 10, 2024.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending

Exit mobile version